Delayed progression of bull's eye maculopathy
- PMID: 28596207
- PMCID: PMC5535135
- DOI: 10.1136/bcr-2017-220598
Delayed progression of bull's eye maculopathy
Abstract
Chloroquine-induced maculopathy may progress years after drug cessation and an apparent period of visual stability. Both doctor and patients should be fully aware of the risks of retinal toxicity, including delayed onset and progression. It is therefore crucial that regular monitoring continues in affected patients, long after the initial diagnosis of maculopathy.
Keywords: Drugs: musculoskeletal and joint diseases; Eye.
© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.Arch Ophthalmol. 2011 Jan;129(1):30-9. doi: 10.1001/archophthalmol.2010.321. Arch Ophthalmol. 2011. PMID: 21220626
-
[Chloroquine-induced bull's eye maculopathy without electrophysiologic changes].Klin Monbl Augenheilkd. 1997 Jun;210(6):400-1. doi: 10.1055/s-2008-1035083. Klin Monbl Augenheilkd. 1997. PMID: 9333669 German.
-
Multimodal imaging in a severe case of hydroxychloroquine toxicity.Ophthalmic Surg Lasers Imaging Retina. 2015 Mar;46(3):377-9. doi: 10.3928/23258160-20150323-14. Ophthalmic Surg Lasers Imaging Retina. 2015. PMID: 25856825
-
Mimickers of hydroxychloroquine retinal toxicity.Clin Exp Ophthalmol. 2024 Dec;52(9):1003-1015. doi: 10.1111/ceo.14461. Epub 2024 Dec 3. Clin Exp Ophthalmol. 2024. PMID: 39626654 Free PMC article. Review.
-
[Chloroquine and hydroxychloroquine maculopathy: a review of diagnostic and therapeutic guidelines in Hungarian and international clinical practice].Orv Hetil. 2024 Jul 28;165(30):1147-1153. doi: 10.1556/650.2024.33094. Print 2024 Jul 28. Orv Hetil. 2024. PMID: 39068644 Review. Hungarian.
Cited by
-
Knowledge of Saudi Patients with Autoimmune Diseases about Hydroxychloroquine Toxicity: The Role of Physician-Patient Communication.Pharmacy (Basel). 2022 Nov 17;10(6):152. doi: 10.3390/pharmacy10060152. Pharmacy (Basel). 2022. PMID: 36412828 Free PMC article.
-
Ophthalmologic implications to consider when using hydroxychloroquine to treat COVID-19 and induced arthritis.World J Exp Med. 2023 Sep 20;13(4):95-98. doi: 10.5493/wjem.v13.i4.95. eCollection 2023 Sep 20. World J Exp Med. 2023. PMID: 37767541 Free PMC article.
-
Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy: One Year Follow-Up.Transl Vis Sci Technol. 2023 Jul 3;12(7):8. doi: 10.1167/tvst.12.7.8. Transl Vis Sci Technol. 2023. PMID: 37418250 Free PMC article.
References
-
- The Royal College of Ophthalmologists. Hydroxychloroquine and ocular toxicity recommendations on screening. 2009. https://www.rcophth.ac.uk/wp-content/uploads/2014/12/2009-SCI-010-Ocular....
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical